Skip to main content
Clinical Trials/CTRI/2024/07/070519
CTRI/2024/07/070519
Not yet recruiting
未知

Assessment of visual outcome and quality of life during the course of treatment with intravitreal anti-VEGF injection in patients with diabetic macular edema. - NI

Ramanpreet Kaur0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: H30-H36- Disorders of choroid and retinaHealth Condition 2: H358- Other specified retinal disorders
Sponsor
Ramanpreet Kaur
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
Ramanpreet Kaur

Eligibility Criteria

Inclusion Criteria

  • Patients with center involving diabetic macular edema requiring anti\-VEGF injections
  • Patients who are already undergoing treatment with intravitreal anti\-VEGF injections

Exclusion Criteria

  • Patients with media opacities due to dense cataract , vitreous hemorrhage etc in whom it is difficult to assess posterior segment
  • Patients with recent stroke less than 3 months who cannot be injected anti\-VEGF
  • Patient with other chronic comorbidities example inability to walk , hearing loss or visual loss due to causes other than DME that may affect quality of life
  • Patients undergoing other intravitreal injections like steroids
  • Patients who are not able to have adequate hearing and sight cognition to be able to complete interview questions

Outcomes

Primary Outcomes

Not specified

Similar Trials